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Endogenous metabolites and inflammasome
activity in early childhood and links to respi-
ratory diseases
To the Editor:
The NLR family, pyrin domain containing 3 (NLRP3) inflam-
masome is a pivotal host platform for sensing of endogenous and
exogenous danger signals and for the subsequent orchestration of
inflammatory responses. Beside pathogenic agents, endogenous
dietary metabolites such as fatty acids can trigger the assembly of
NLRP3 inflammasomes, cytosolic protein complexes that acti-
vate caspase-1 (CASP1), leading to the cleavage of pro–IL-1b
and pro–IL-18.1 NLRP3 and the expression of pro forms of the IL-
1b cytokine family are transcriptionally induced by Toll like re-
ceptor (TLR) activation. Although the link between glucose or
fatty acids and the activation of NLRP3 inflammasome is well es- 2015 The Authors. Published by Elsevier, Inc. on behalf of the Academy of Allergy,
Asthma& Immunology. This is an open access article under the CCBY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/4.0/).tablished in mice,2 comparable data for humans were reported
only for adipose tissue.3 Studies for children are completely
missing so far. Therefore, in the present study, our aim was to
investigate whether the metabolic state is associated with the
immature immune system already in early childhood. By per-
forming a broadmetabolic profiling, we explored the involvement
of endogenous metabolites in the expression of TLR and NLRP3
inflammasome components in children at birth and at age 1 year
using samples from the prospective birth cohort LINA (Lifestyle
and environmental factors and their Influence on Newborns Al-
lergy risk).4
In the LINA study, 629 mother-child pairs (622 mothers and
7 twin pairs) were recruited from March 2006 until December
2008 in Leipzig, Germany.4 Annually, around the birthday of
the child, follow-up investigations were performed with ques-
tionnaire evaluations for respiratory (wheezing, airway infec-
tions, bronchitis, asthma) and allergic (atopic dermatitis, hay
fever, allergic sensitization) outcomes and clinical visits
including blood collection. In children’s blood samples at birth
(cord blood, n 5 471) and at age 1 year (n 5 513), mRNA
expression for NLRP3, CASP1, MyD88, TLR1, TLR2,
TLR5, TLR6, TLR7, TLR9, and TLR10 as well as the concen-
tration of the effector cytokines IL-1b (protein and mRNA),
IL-18 (mRNA), and specific IgE was measured. Metabolomic
analysis was performed in sera of 495 newborns (cord blood)
and 449 1-year-old children by using the AbsoluteIDQ p180
Kit (Biocrates Life Science AG, Innsbruck, Austria). Method
details, characteristics of the study population, median values,
and interquartile ranges for all metabolites and immune param-
eters are given in Tables E2-E4 in this article’s Online
Repository at www.jacionline.org.
At birth as well as in the first year of life, high hexose levels
correlated with increased expression of TLRs and CASP1 and in
part with NLRP3. Contrarily, a reduced expression of TLRs and
inflammasome components was measured in the presence of
high concentrations of amino acids and lysophosphatidylcho-
lines (lysoPCs). To control for multitesting, we applied a
Bonferroni correction (significance level P < 4.2 3 1024) and
could show that the observed associations between metabolites
and immune/inflammasome parameters remained significant
(data are presented as heat maps of Spearmen correlation coef-
ficients) (Fig 1). Furthermore, by calculating mean ratios
adjusted for the possible confounding factors season of birth,
mode of delivery, cat keeping, parental history of atopy, sex,
and parental education, the entirely detected relationships re-
mained significant (see Figs E2 and E3 in this article’s Online
Repository at www.jacionline.org). Although the concentration
of metabolites and inflammatory parameters at birth did not
correlate with concentrations in the first year of life (see
Tables E3 and E4), the relationship between metabolites and in-
flammatory parameters at each time point was nearly identical
(Fig 1). These findings indicate that there is a valid relationship
between sugars, lysoPCs, amino acids, and TLRs/inflamma-
some components that is dynamically modulated by the meta-
bolic state.
It is obvious from in vitro and in vivo animal studies that high
glucose levels provide a priming signal for IL-1b by activation of
thioredoxin-interactin protein, which subsequently binds to
NLRP3, inducing IL-1b secretion in islet cells.2 In addition,
high concentrations of glucose induce the generation of reactive
oxygen species, which is a sufficient second signal for promoting
FIG 1. Heat maps present the correlation between bloodmetabolite concentrations and expression of TLRs/
MyD88 and inflammasome components (NLRP3/CASP1) at birth (cord blood) and in the first year of life (1
year). The color of each cell in the heat map represents the correlation coefficient (R) from Spearman cor-
relation. Only significant values after Bonferroni correction (P < 4.2 3 1024) are presented.
TABLE I. Relationship between IL-1b protein and IL-1bmRNA concentrations at birth (cord blood), 1-year blood, and the development of
childhood diseases in the first (1 y) and second year (2 y) of life, respectively*
IL-1b protein blood concentrations IL-1b mRNA blood expression
Birth 1 y Birth 1 y
aOR (95% CI)
Outcome at age 1 y 2 y 1 y 2 y
Atopic dermatitis 0.97 (0.74-1.28) 1.26 (0.97-1.63) 0.98 (0.74-1.31) 0.81 (0.58-1.15)
Sensitization:
to food allergens 1.13 (0.88-1.46) 1.04 (0.80-1.35) 0.99 (0.76-1.28) 0.86 (0.62-1.19)
to inhalant allergens 1.33 (0.75-2.38) 0.92 (0.63-1.34) 1.02 (0.56-1.87) 0.84 (0.52-1.36)
Bronchitis 1.25 (1.01-1.54)§ 1.23 (1.05-1.44)§ 0.91 (0.73-1.13) 1.23 (1.00-1.50)§
Wheezing 1.15 (0.93-1.42) 1.11 (0.93-1.32) 1.26 (1.00-1.54)§ 1.27 (1.01-1.59)§
Airway infections 1.62 (0.88-2.99) 1.09 (0.90-1.32) 1.02 (0.83-1.24) 1.07 (0.84-1.36)
aOR, Adjusted odds ratio.
*Analysis was performed using a logistic regression model with IL-1b values categorized in quartiles.
aOR for parental educational level, month of birth, mode of delivery, cat keeping during pregnancy, siblings, sex, and smoking during pregnancy. Atopic dermatitis and allergic
sensitization were additionally adjusted for parental history of atopy.
According to the Phadia CAP System, concentrations of more than 0.35 kU/L were regarded as positive.
§Significant numbers are in boldface (P < .05).
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LETTERS TO THE EDITOR 497inflammasome activation.2 Our epidemiological data show that
at least in cord blood, the NLRP3 expression is associated with
high hexoses levels. Furthermore, the expression of the NLRP3
downstream target CASP1 was strongly correlated with high
hexose levels at birth as well as in the first year. We validated
these findings by performing in vitro assays using PBMCs
from healthy adult donors and demonstrated that glucose induces
a higher expression of NLRP3, CASP1, as well as IL1B (see Fig
E7 in this article’s Online Repository at www.jacionline.org).
In vitro experiments with human monocytes already demon-
strated that high glucose induces TLRmRNA expression,5 which
is in line with our results showing that elevated blood concentra-
tion of hexoses is related to increased mRNA expression of TLRs
and the adaptor molecule MyD88 at both analyzed time points.
Our in vitro data again support this result by showing a
glucose-induced activation of MYD88 (Fig E7). Earlier experi-
mental studies show that the Nlrp3 promotor is activated by
TLR/MyD88-mediated signaling.6 Our data support these re-
sults; we found that increased expression of TLRs/MyD88 corre-
lated with increased expression of NLRP3 and CASP1 (see Figs
E4 and E5 in this article’s Online Repository at www.jacionline.
org). We could furthermore show that both NLRP3 and CASP1
were related to the expression of the effector cytokines IL-1b
(mRNA and protein) and IL-18 (mRNA) (see Fig E6 in this arti-
cle’s Online Repository at www.jacionline.org). Thus, our re-
sults may provide the first evidence that the association
between hyperglycemia, inflammasome activation, and IL-1b
production reported so far only in animal models2 is also present
in humans.
As further metabolites linked to inflammasome activity we
have identified amino acids and lysoPCs. Our results may point
to an anti-inflammatory effect of both groups showing a strong
negative association with TLR and inflammasome component
expression. These data are in line with previous reports
showing that lysoPCs may act as attenuators of sepsis and as
immune suppressors7,8 whereas dietary supplementation with
certain amino acids (eg, valine, histidine, and arginine) was re-
ported to alleviate tissue and systemic inflammation.9,10 Our
in vitro data sustain these findings at least for amino acid
(valine) treatment where we observed a diminished expression
of CASP1, IL1B, and MyD88 but not of NLRP3 and the
analyzed TLRs.
On the basis of our data and findings from other groups, it is
reasonable that an imbalance between endogenous metabolites
(eg, elevated glucose levels and reduced amino acid levels)
may lead to an increased inflammatory status. Indeed, in our
study, molecules capable of sensing metabolites (TLRs and
NLRP3/CASP1) were associated with increased concentrations
of the effector cytokines IL-1b and IL-18. The role of these
cytokines for the development of childhood diseases is poorly
investigated. Here, we found that cord blood IL-1b (Table I)
but not IL-18 (Table E5) concentrations were predictive for
the development of bronchitis and wheezing by age 2 years.
Thus, the balance between endogenous metabolites seems to
be important for the regulation of an inflammatory immune
response independently of invading pathogens. Because we
could show that the inflammasome effector cytokine IL-1b
was linked to a higher risk of respiratory diseases during the
first 2 years of life, our results may give evidence that the me-
tabolome is of importance for respiratory diseases in early
childhood.We thank all LINA participants as well as Anne Hain, Beate Fink, and
Gabriele Heimpold for their excellent technical assistance and Melanie
Nowak for her study organization assistance.
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The influence of asthma control on the severity
of virus-induced asthma exacerbations
To the Editor:
Our understanding of asthma control has evolved in recent
years to include both the idea of current control (gauged mostly
